We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
Cap. Flow
-$1.58B
Cap. Flow %
-0.53%
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1B
2
AAPL icon
Apple
AAPL
+$797M
3
MRK icon
Merck
MRK
+$316M
4
AMZN icon
Amazon
AMZN
+$308M
5
MDT icon
Medtronic
MDT
+$298M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Healthcare 13.29%
3 Consumer Discretionary 13.23%
4 Financials 12.2%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIVB icon
2601
Civista Bancshares
CIVB
$589M
$1.58M ﹤0.01%
90,033
+947
+1% +$15K
IMXI icon
2602
International Money Express
IMXI
$367M
$1.57M ﹤0.01%
100,957
+15,085
+18% +$234K
SYRS
2603
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.57M ﹤0.01%
14,441
-3,675
-20% -$335K
EQBK icon
2604
Equity Bancshares
EQBK
$1.05B
$1.56M ﹤0.01%
72,273
-13,407
-16% -$261K
BFST icon
2605
Business First Bancshares
BFST
$1.03B
$1.56M ﹤0.01%
76,657
+783
+1% +$14.5K
DJCO icon
2606
Daily Journal
DJCO
$778M
$1.56M ﹤0.01%
3,852
-250
-6% -$70.9K
BFC icon
2607
Bank First Corp
BFC
$1.7B
$1.56M ﹤0.01%
24,006
+15
+0.1% +$984
RBCAA icon
2608
Republic Bancorp
RBCAA
$1.95B
$1.55M ﹤0.01%
43,064
-210
-0.5% -$7.33K
VSTM icon
2609
Verastem
VSTM
$610M
$1.55M ﹤0.01%
60,702
+2,052
+3% +$41.2K
MAX icon
2610
MediaAlpha
MAX
$821M
$1.55M ﹤0.01%
+39,604
New +$1.54M
MCB icon
2611
Metropolitan Bank Holding Corp
MCB
$1.15B
$1.55M ﹤0.01%
42,624
-2,150
-5% -$69.6K
CCNE icon
2612
CNB Financial Corp
CCNE
$1.03B
$1.54M ﹤0.01%
72,586
+342
+0.5% +$6.58K
OLP
2613
One Liberty Properties
OLP
$527M
$1.54M ﹤0.01%
76,586
+504
+0.7% +$9.03K
FRPH icon
2614
FRP Holdings
FRPH
$421M
$1.52M ﹤0.01%
66,834
-3,910
-6% -$85.8K
CLFD icon
2615
Clearfield
CLFD
$374M
$1.52M ﹤0.01%
61,355
+18,297
+42% +$428K
QTTB icon
2616
Q32 Bio
QTTB
$464M
$1.52M ﹤0.01%
7,461
+395
+6% +$76.3K
ARAY icon
2617
Accuray
ARAY
$34M
$1.51M ﹤0.01%
362,194
-14,763
-4% -$54.2K
EVC icon
2618
Entravision Communication
EVC
$1.1B
$1.51M ﹤0.01%
548,719
+4,305
+0.8% +$10.4K
AMTI
2619
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$1.5M ﹤0.01%
48,898
+2,542
+5% +$80.6K
SUMO
2620
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
$1.5M ﹤0.01%
+52,535
New +$1.24M
IBRX icon
2621
ImmunityBio
IBRX
$8.1B
$1.5M ﹤0.01%
112,537
-731
-0.6% -$7.03K
NIU
2622
Niu Technologies
NIU
$193M
$1.49M ﹤0.01%
53,227
+26,300
+98% +$763K
MBIN icon
2623
Merchants Bancorp
MBIN
$2.49B
$1.49M ﹤0.01%
80,967
+6,205
+8% +$103K
HAYN
2624
DELISTED
Haynes International, Inc.
HAYN
$1.49M ﹤0.01%
62,521
+205
+0.3% +$4.26K
BIP icon
2625
Brookfield Infrastructure Partners
BIP
$18B
$1.49M ﹤0.01%
45,197
+31,173
+222% +$1.02M

Similar funds

Nuveen's Q4 2020 Portfolio in Review

As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
  • Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
  • Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
  • Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
  • Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
  • Nuveen opened 145 new positions and closed 125 in Q4 2020.
  • Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.